Know Cancer

forgot password

Abiraterone Acetate Treatment for Prostate Cancer Patients With a PSA of More Than Four Following Initial Androgen Deprivation Therapy Phase II

Phase 2
18 Years
Open (Enrolling)
Prostate Cancer

Thank you

Trial Information

Abiraterone Acetate Treatment for Prostate Cancer Patients With a PSA of More Than Four Following Initial Androgen Deprivation Therapy Phase II



- To assess the rate of achieving a prostate-specific antigen (PSA) of ≤ 0.2 ng/mL with
abiraterone acetate therapy in men with metastatic prostate cancer with a sub-optimal
response to androgen-deprivation therapy (ADT).


- To assess the overall survival and objective progression-free survival of this group of

- To assess PSA partial response.

- To evaluate the qualitative and quantitative toxicity of abiraterone acetate.

OUTLINE: This is a multicenter study.

Patients receive abiraterone acetate orally daily on days 1-28. Courses repeat every 28 days
in the absence of disease progression or unacceptable toxicity.

Patients receive androgen blockade with GNRH agonist (goserelin acetate or leuprolide
acetate) or a GNRH antagonist (degarelix) per the treating physician and this will be given
continuously until evidence of disease progression. Bilateral surgical orchiectomy is also

After completion of study therapy, patients are followed up every 3 months for 1 year and
then every 6 months for up to 3 years.

Inclusion Criteria


- Histologically or cytologically proven diagnosis of adenocarcinoma of the prostate

- Metastatic (M1) disease as evidenced by soft tissue and/or bony metastases at
the time of initiation of androgen-deprivation therapy (ADT)

- Must have at least one of the following:

- Visceral disease (liver, lung, other viscera)

- Bone metastases to sites in either the axial (spine, pelvis, ribs, or
skull) and/or the appendicular (clavicle, humerus, or femur) skeleton

- Distant lymph node disease (e.g., above the aortic bifurcation, etc.)

- No small cell or neuroendocrine prostate cancer

- Patients must be receiving ADT (e.g., gonadotropin-releasing hormone [GNRH]
antagonist, with or without antiandrogen) prior to entering this study

- Degarelix, a FDA-approved GNRH antagonist, is an acceptable form of ADT

- Bilateral surgical orchiectomy is also acceptable

- Suboptimal response to ADT induction as defined by the following criteria:

- Declining PSA (current PSA is less than the PSA prior to starting ADT) that
fails to reach 4 ng/mL or below despite continuous ADT

- PSA of > 4 ng/mL must be observed between 6-12 months after the initiation
of ADT

- Documentation of failure to achieve this PSA of ≤ 4 ng/mL must be within 28
days of registration

- The PSA must be obtained after any applicable antiandrogen washout

- If the PSA is declining or stable (defined as a PSA rise ≤ 0.1 ng/mL from
nadir) and the patient is on an antiandrogen, they must remain on the

- Patients with stable or declining PSA who have had previous antiandrogen
exposure, but are not taking an antiandrogen at the time of registration,
must wait at least 6 weeks from the last antiandrogen dose before
registration and still demonstrate a stable or falling PSA which is > 4
ng/mL by month 12, in order to be eligible

- If the PSA is rising and they are on an antiandrogen, formal antiandrogen
washout must be performed (4 weeks for flutamide and 6 weeks for
bicalutamide and nilutamide with no evidence of a falling PSA after

- No patients with radiographic progression when compared to available imaging
studies performed prior to starting the GNRH agonist/antagonist therapy

- Patients who have measurable disease must have radiographic assessment (at least an
abdominal/pelvic CT scan) within 28 days prior to registration

- Non-measurable disease must be assessed (i.e., bone scan) within 42 days prior to

- No patients with a history of brain metastases or who currently have treated or
untreated brain metastases

- Patients with clinical evidence of brain metastases must have a brain CT scan or
MRI negative for metastatic disease within 56 days prior to registration


- Zubrod performance status 0-2

- ANC ≥ 1,500/μL

- Platelet count ≥ 100,000/μL

- Hemoglobin ≥ 10 g/dL

- Serum creatinine ≤ 1.5 times the upper limit of normal (ULN) OR creatinine clearance
≥ 60 mL/min

- Bilirubin ≤ 1.5 times ULN (unless documented Gilbert disease)

- AST and ALT < 1.5 times ULN

- Potassium ≥ 3.5 mmol/L

- Patient must have a testosterone value of < 50 ng/dL obtained within 28 days prior to

- Patients must have controlled blood pressure defined as systolic blood pressure < 160
mm Hg and diastolic blood pressure < 95 mm Hg

- Patients with a history of hypertension are eligible provided blood pressure is
controlled by anti-hypertensive treatment

- Patients who have partners of child-bearing potential must be willing to use a method
of birth control with adequate barrier protection during the study and for 1 week
after the last study drug administration

- Must be able to take oral medication without crushing, dissolving, or chewing tablets

- Patients must not have a history of gastrointestinal disorders (medical disorders or
extensive surgery) that may interfere with the absorption of abiraterone acetate

- No other prior malignancy is allowed except for any of the following:

- Adequately treated basal cell or squamous cell skin cancer

- Adequately treated stage I or II cancer from which the patient is currently in
complete remission

- Any other cancer from which the patient has been disease-free for 5 years

- No patients with active or symptomatic viral hepatitis or chronic liver disease

- No moderate (Child-Pugh B) or severe (Child-Pugh C) hepatic impairment

- No history of NYHA class III or IV heart failure

- Patients must have LVEF ≥ 50%

- No known allergies, hypersensitivity, or intolerance to abiraterone acetate,
prednisone, or their excipients


- See Disease Characteristics

- Patients with a history of prior neoadjuvant or adjuvant GNRH agonist/antagonist
therapy (related to previous surgery or radiation) are eligible provided they
finished this therapy at least two years prior to registration

- Prior enrollment to SWOG-S0925 (either arm) is not exclusionary

- At least 6 weeks since prior and no concurrent finasteride or dutasteride

- At least 28 days since prior radiotherapy or surgery and recovered

- At least 4 weeks since prior investigational products

- At least 4 weeks since prior flutamide (6 weeks for bicalutamide and nilutamide) with
no evidence of a falling PSA

- No other concurrent oral antiandrogen

- No prior or concurrent cytotoxic chemotherapy or radiopharmaceuticals for prostate

- No prior or concurrent ketoconazole for the treatment of prostate cancer

- Not requiring more than 10 mg a day of prednisone for another medical indication

- Not planning to receive any concurrent cytotoxic chemotherapy, immunotherapy,
surgery, or radiotherapy during protocol treatment

- No concurrent hormonal-acting agents, including diethylstilbestrol/DES, aldosterone,
PC-SPES, or spironolactone

- No concurrent antifungal medication (e.g., fluconazole or itraconazole)

- No medications that alter cardiac conduction

- No prior Provenge (sipuleucel-T)

Type of Study:


Study Design:

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Rates of undetectable PSA

Outcome Time Frame:

12 months

Safety Issue:


Principal Investigator

Thomas W. Flaig, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Colorado, Denver


United States: Food and Drug Administration

Study ID:




Start Date:

September 2011

Completion Date:

June 2015

Related Keywords:

  • Prostate Cancer
  • adenocarcinoma of the prostate
  • hormone-resistant prostate cancer
  • stage IV prostate cancer
  • recurrent prostate cancer
  • Prostatic Neoplasms



University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan  48109-0752
Cardinal Bernardin Cancer Center at Loyola University Medical Center Maywood, Illinois  60153-5500
Barbara Ann Karmanos Cancer Institute Detroit, Michigan  48201
Tripler Army Medical Center Honolulu, Hawaii  96859-5000
CCOP - Wichita Wichita, Kansas  67214-3882
Hurley Medical Center Flint, Michigan  48503
St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center Grand Junction, Colorado  81502
CCOP - Michigan Cancer Research Consortium Ann Arbor, Michigan  48106
Saint Joseph Mercy Cancer Center Ann Arbor, Michigan  48106-0995
Oakwood Cancer Center at Oakwood Hospital and Medical Center Dearborn, Michigan  48123-2500
Genesys Hurley Cancer Institute Flint, Michigan  48503
Van Elslander Cancer Center at St. John Hospital and Medical Center Grosse Pointe Woods, Michigan  48236
Sparrow Regional Cancer Center Lansing, Michigan  48912-1811
St. John Macomb Hospital Warren, Michigan  48093
CCOP - Cancer Research for the Ozarks Springfield, Missouri  65807
CCOP - Montana Cancer Consortium Billings, Montana  59101
CCOP - Columbus Columbus, Ohio  43206
CCOP - Grand Rapids Grand Rapids, Michigan  49503
Charles M. Barrett Cancer Center at University Hospital Cincinnati, Ohio  45267-0526
CCOP - Scott and White Hospital Temple, Texas  76508
MultiCare Regional Cancer Center at Tacoma General Hospital Tacoma, Washington  98405
Cancer Research Center of Hawaii Honolulu, Hawaii  96813
CCOP - St. Louis-Cape Girardeau Saint Louis, Missouri  63141
Veterans Affairs Medical Center - Houston Houston, Texas  77030
CCOP - Northwest Tacoma, Washington  98405-0986
Kaiser Permanente Medical Center - Vallejo Vallejo, California  94589
University of California Davis Cancer Center Sacramento, California  95817
Kaiser Permanente Medical Center - San Francisco Geary Campus San Francisco, California  94115
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas  72205
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center Kansas City, Kansas  66160-7353
Josephine Ford Cancer Center at Henry Ford Hospital Detroit, Michigan  48202
Thompson Cancer Survival Center Knoxville, Tennessee  37916
Hulston Cancer Center at Cox Medical Center South Springfield, Missouri  65807
St. John's Regional Health Center Springfield, Missouri  65804
Winthrop University Hospital Mineola, New York  11501
Central Baptist Hospital Lexington, Kentucky  40503
Kaiser Permanente Medical Center - Oakland Sacramento, California  95825
Via Christi Cancer Center at Via Christi Regional Medical Center Wichita, Kansas  67214
Presbyterian Cancer Center at Presbyterian Hospital Charlotte, North Carolina  28233-3549
Hollings Cancer Center at Medical University of South Carolina Charleston, South Carolina  29425
Baylor University Medical Center - Houston Houston, Texas  77030-2399
James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York  14642
Good Samaritan Regional Health Center Mt. Vernon, Illinois  62864
Battle Creek Health System Cancer Care Center Battle Creek, Michigan  49017
Northern Michigan Hospital Petoskey, Michigan  49770
Munson Medical Center Traverse City, Michigan  49684
David C. Pratt Cancer Center at St. John's Mercy St. Louis, Missouri  63141
Hematology-Oncology Centers of the Northern Rockies - Billings Billings, Montana  59101
St. Peter's Hospital Helena, Montana  59601
Kalispell Regional Medical Center Kalispell, Montana  59901
Glacier Oncology, PLLC Kalispell, Montana  59901
Montana Cancer Center at St. Patrick Hospital and Health Sciences Center Missoula, Montana  59802
Montana Cancer Specialists at Montana Cancer Center Missoula, Montana  59802
Wayne Memorial Hospital, Incorporated Goldsboro, North Carolina  27534
Adena Regional Medical Center Chillicothe, Ohio  54601
Doctors Hospital at Ohio Health Columbus, Ohio  43228
Riverside Methodist Hospital Cancer Care Columbus, Ohio  43214
Grady Memorial Hospital Delaware, Ohio  43015
Fairfield Medical Center Lancaster, Ohio  43130
Strecker Cancer Center at Marietta Memorial Hospital Marietta, Ohio  45750
Licking Memorial Cancer Care Program at Licking Memorial Hospital Newark, Ohio  43055
Community Hospital of Springfield and Clark County Springfield, Ohio  45505
Genesis - Good Samaritan Hospital Zanesville, Ohio  43701
Kaiser Permanente Medical Center - Santa Clara Kiely Campus Santa Clara, California  95051-5386
M.D. Anderson Cancer Center at Orlando Orlando, Florida  32806
Mountain States Tumor Institute at St. Luke's Regional Medical Center Boise, Idaho  83712-6297
Tulane Cancer Center Office of Clinical Research Alexandria, Louisiana  71315-3198
Butterworth Hospital at Spectrum Health Grand Rapids, Michigan  49503-2560
University of Mississippi Cancer Clinic Jackson, Mississippi  39216-4505
CCOP - Nevada Cancer Research Foundation Las Vegas, Nevada  89109-2306
University of New Mexico Cancer Center Albuquerque, New Mexico  87131-5636
St. Luke's - Roosevelt Hospital Center - St.Luke's Division New York, New York  10027
Kaiser Permanente Medical Center - Sacramento Sacramento, California  95825
Huntsman Cancer Institute at University of Utah Salt Lake City, Utah  84112
Decatur Memorial Hospital Cancer Care Institute Decatur, Illinois  62526
Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center Hartford, Connecticut  06105
Mount Carmel Health - West Hospital Columbus, Ohio  43222
Front Range Cancer Specialists Fort Collins, Colorado  80528
University Medical Center of Southern Nevada Las Vegas, Nevada  89102
Kaiser Permanente - Fremont Fremont, California  94538
Kaiser Permanente Medical Center - Hayward Hayward, California  94545
Kaiser Permanente Medical Center - Redwood City Redwood City, California  94063
Kaiser Permanente Medical Center - Richmond Richmond, California  94801
Kaiser Permanente Medical Center - Roseville Roseville, California  95661
South Sacramento Kaiser-Permanente Medical Center Sacramento, California  95823
Kaiser Permanente Medical Center - Santa Teresa San Jose, California  95119
Kaiser Foundation Hospital - San Rafael San Rafael, California  94903
Kaiser Permanente Medical Center - Santa Rosa Santa Rosa, California  95403
Kaiser Permanente Medical Center - South San Francisco South San Francisco, California  94080
Kaiser Permanente Medical Facility - Stockton Stockton, California  95210
Kaiser Permanente Medical Center - Walnut Creek Walnut Creek, California  94596
Poudre Valley Hospital Fort Collins, Colorado  80524
Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center Boise, Idaho  83706
Genesis Regional Cancer Center at Genesis Medical Center Davenport, Iowa  52803
Cancer Center of Kansas, PA - Dodge City Dodge City, Kansas  67801
St. Francis Comprehensive Cancer Center Topeka, Kansas  66606
Feist-Weiller Cancer Center at Louisiana State University Health Sciences Shreveport, Louisiana  71130-3932
Bay Regional Medical Center Bay City, Michigan  48708
Mecosta County Medical Center Big Rapids, Michigan  49307
Saint Francis Medical Center Cape Girardeau, Missouri  63701
Iredell Memorial Hospital Statesville, North Carolina  28677
Christine LaGuardia Phillips Cancer Center at Wellmont Holston Valley Medical Center Kingsport, Tennessee  37662
UMC Southwest Cancer and Research Center Lubbock, Texas  79415-3364
Montrose Memorial Hospital Cancer Center Montrose, Colorado  81401
St. Francis Hospital Federal Way, Washington  98003
St. Clare Hospital Lakewood, Washington  98499-0998
Providence St. Peter Hospital Regional Cancer Center Olympia, Washington  98506
Good Samaritan Cancer Center Puyallup, Washington  98371
Allenmore Hospital Tacoma, Washington  98411-0414
Kaiser Permanente - Deer Valley Antioch, California  94531
Kaiser Permanente - Moanalua Medical Center and Clinic Honolulu, Hawaii  96819
Cancer Center of Kansas, PA - Chanute Chanute, Kansas  66720
Cancer Center of Kansas - Fort Scott Fort Scott, Kansas  66701
Cancer Center of Kansas-Independence Independence, Kansas  67301
Cancer Center of Kansas, PA - Kingman Kingman, Kansas  67068
Lawrence Memorial Hospital Lawrence, Kansas  66044
Cancer Center of Kansas, PA - Liberal Liberal, Kansas  67905
Cancer Center of Kansas, PA - Newton Newton, Kansas  67114
Cancer Center of Kansas, PA - Parsons Parsons, Kansas  67357
Cancer Center of Kansas, PA - Pratt Pratt, Kansas  67124
Tammy Walker Cancer Center at Salina Regional Health Center Salina, Kansas  67401
Cancer Center of Kansas, PA - Salina Salina, Kansas  67401
Cotton-O'Neil Cancer Center Topeka, Kansas  66606
Cancer Center of Kansas, PA - Wellington Wellington, Kansas  67152
Cancer Center of Kansas, PA - Wichita Wichita, Kansas  67214
Associates in Womens Health, PA - North Review Wichita, Kansas  67208
Cancer Center of Kansas, PA - Medical Arts Tower Wichita, Kansas  67208
Cancer Center of Kansas, PA - Winfield Winfield, Kansas  67156
Foote Memorial Hospital Jackson, Michigan  49201
St. Mary Mercy Hospital Livonia, Michigan  48154
St. Joseph Mercy Oakland Pontiac, Michigan  48341-2985
Mercy Regional Cancer Center at Mercy Hospital Port Huron, Michigan  48060
Seton Cancer Institute at Saint Mary's - Saginaw Saginaw, Michigan  48601
Truman Medical Center - Hospital Hill Kansas City, Missouri  64108
Billings Clinic - Downtown Billings, Montana  59107-7000
Bozeman Deaconess Cancer Center Bozeman, Montana  59715
Great Falls Clinic - Main Facility Great Falls, Montana  59405
Sletten Cancer Institute at Benefis Healthcare Great Falls, Montana  59405
Grant Medical Center Cancer Care Columbus, Ohio  43215
Knox Community Hospital Mount Vernon, Ohio  43050
Mount Carmel St. Ann's Cancer Center Westerville, Ohio  43081
Providence Centralia Hospital Centralia, Washington  98531-9027
Franciscan Cancer Center at St. Joseph Medical Center Tacoma, Washington  98405-3004
Rocky Mountain Oncology Casper, Wyoming  82609
Regional Cancer Center at Memorial Medical Center Springfield, Illinois  62781-0001
Ben Taub General Hospital Houston, Texas  77030
Queen's Cancer Institute at Queen's Medical Center Honolulu, Hawaii  96813
Tucker Center for Cancer Care at Orange Regional Medical Center Middletown, New York  10940-4199
New Mexico Cancer Care Associates Santa Fe, New Mexico  87505-7670
McLeod Regional Medical Center Florence, South Carolina  29501
Highlands Oncology Group - Springdale Springdale, Arkansas  72764
Mid-Illinois Hematology-Oncology Associates at Community Cancer Center Normal, Illinois  61761
Lacks Cancer Center at Saint Mary's Health Care Grand Rapids, Michigan  49503
St. Vincent Healthcare Cancer Care Services Billings, Montana  59101
Midwest Hematology Oncology Group, Incorporated Saint Louis, Missouri  63109
Tibotec Therapeutics - Division of Ortho Biotech Products, LP Marysville, California  95901
Tahoe Forest Cancer Center Truckee, California  96161
Kapiolani Medical Center at Pali Momi Aiea, Hawaii  96701
Kapiolani Medical Center for Women and Children Honolulu, Hawaii  96826
Straub Clinic and Hospital, Incorporated Honolulu, Hawaii  96813
OnCare Hawaii, Incorporated - Kuakini Honolulu, Hawaii  96817
OnCare Hawaii, Incorporated - Lusitana Honolulu, Hawaii  96813
Mercy General Health Partners Muskegon, Michigan  49443
Valley Hospital - Ridgewood Ridgewood, New Jersey  07450
Hematology-Oncology Clinic Baton Rouge, Louisiana  70808
University of Colorado Cancer Center at UC Health Sciences Center Aurora, Colorado  80045
Hematology Oncology Associates, PC Albuquerque, New Mexico  87106
Memorial Hospital Cancer Center - Colorado Springs Colorado Springs, Colorado  80909
St. Luke's Texas Cancer Institute at St. Luke's Episcopal Hospital Houston, Texas  77030
Mount Carmel Regional Cancer Center Pittsburg, Kansas  66762
Caritas Holy Family Hospital Methuen, Massachusetts  01844
Falck Cancer Center at Arnot Ogden Medical Center Elmira, New York  14905
Shaw Regional Cancer Center Edwards, Colorado  81632
Kansas City Cancer Centers - Southwest Overland Park, Kansas  66210
San Luis Valley Regional Medical Center Alamosa, Colorado  81101
Valley View Hospital Cancer Center Glenwood Springs, Colorado  81601
Castle Medical Center Kailua, Hawaii  96734
Kauai Medical Clinic Lihue, Hawaii  96766
Hays Medical Center Hays, Kansas  67601
Hutchinson Hospital Corporation Hutchinson, Kansas  67502
Clemens Regional Medical Center Mount Clemens, Michigan  48043
Saint Luke's Mountain States Tumor Institute Boise, Idaho  83712
Highland Clinic Shreveport, Louisiana  71105
Southern Ohio Medical Center Cancer Center Portsmouth, Ohio  45662
McLaren Cancer Institute Flint, Michigan  48532
Kansas City Cancer Centers - North Kansas City, Missouri  64154
Kansas City Cancer Centers - South Kansas City, Missouri  64131
Kuakini Medical Center Honolulu, Hawaii  96817
Saint Luke's Mountain States Tumor Institute - Fruitland Fruitland, Idaho  83619
Mountain States Tumor Institute - Meridian Meridian, Idaho  83642
Mountain States Tumor Institute at St. Luke's Twin Falls, Idaho  83301
St. Rose Ambulatory and Surgery Center Great Bend, Kansas  67530
Kansas City Cancer Centers - West Kansas City, Kansas  66112
Kansas City Cancer Center - Shawnee Mission Shawnee Mission, Kansas  66204
Kansas City Cancer Centers - East Lee's Summit, Missouri  64064
Spectrum Health Reed City Hospital Reed City, Michigan  49677
Providence Regional Cancer Partnership Everett, Washington  98201
Kaiser Permanente Medical Center - Vacaville Vacaville, California  95688
St. Joseph Regional Medical Center Lewiston, Idaho  83501
Oncare Hawaii, Incorporated - Pali Momi Aiea, Hawaii  96701
Kaiser Permanente Fresno Medical Center Fresno, California  93720
Singh and Arora Hematology Oncology, PC Flint, Michigan  48532
Great Lakes Cancer Institute - Lapeer Campus Lapeer, Michigan  48446
NEA Medical Clinic - East Matthews Jonesboro, Arkansas  72401
Cancer Center of Acadiana at Lafayette General Medical Center Lafayette, Louisiana  70503